Weekly insulin icodec is more effective than daily basal insulin at reducing HbA1c
1. In this randomized controlled trial, insulin icodec demonstrated superior HbA1c reduction as compared to once-daily basal insulin analogs in...
Recurrence is high in patients with transient atrial fibrillation during hospitalization
1. In this matched cohort study, approximately one in three patients who had transient new-onset atrial fibrillation (AF) during hospitalization...
Five modifiable risk factors contribute to cardiovascular disease and mortality
1. In this retrospective cohort study, five risk factors (body mass index, systolic blood pressure, non–high-density lipoprotein cholesterol, current smoking,...
Semaglutide improves symptoms in patients with heart failure
1. In this randomized controlled trial, in patients with heart failure with preserved ejection fraction semaglutide treatment led to reductions...
Solanezumab does not slow cognitive decline in patients with Alzheimer’s disease
1. In this randomized controlled trial, over a period of 240 weeks, solanezumab did not slow cognitive decline as compared...
Edoxaban does not improve outcomes in patients with atrial high-rate episodes
1. In this randomized controlled trial, edoxaban did not significantly reduce the incidence of a composite of cardiovascular death, stroke,...
Evening chronotype in middle-aged nurses is associated with an increased diabetes risk
1. In this prospective cohort study, middle-aged nurses with an evening chronotype were more likely to develop type two diabetes. ...
Pegozafermin associated with improved outcomes in nonalcoholic steatohepatitis
1. In this randomized controlled trial, treatment with pegozafermin improved fibrosis in patients with nonalcoholic steatohepatitis (NASH). 2. Treatment with...
Low achievement of guideline-recommended diabetes targets in Chinese adults
1. In this cross-sectional study, the proportion of Chinese adults with self-reported type 2 diabetes who achieved a guideline-recommended HbA1c...
Generic and brand-name fluticasone-salmeterol are equally effective in COPD management
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease...